In every issue, you'll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Advocates born with HIV face ongoing challenges.
Could 2017 be a pivotal year for homeless youth and HIV?
POZ catches up with Jake Glaser, Hydeia Broadbent and the Meredith siblings for our special issue on youth.
Founded by youth activists, TruEvolution uses education and leadership to empower underserved LGBT youth.
An HIV/AIDS art exhibit centers on youth.
Accuracy Watchdog corrects erroneous reporting about HIV transmission risks.
They're mostly straight, white, rural and poor.
Can you get HIV from eating bananas?
Actress and playwright Nora Burns explores the loss of her best friend to AIDS in 1993 in her show David’s Friend.
Instagram account shares touching visual tributes to the many lives lost to AIDS.
The results are in.
Phase III trial begins for long-acting injectable form of the experimental antiretroviral cabotegravir for use as PrEP against HIV.
Two large studies have found that the two-drug combination of Tivicay and Edurant works as well as standard three- or four-ARV regimens.
Pharmaceutical giant Gilead Sciences has awarded over $22 million in grants for 12 HIV-cure-focused research projects.
Young people may avoid seeking sexual and reproductive health care out of concern that their parents will find out about it.
Researchers have succeeded in charting the structure of a tool central to HIV’s effort to splice its genetic code into a human cell's DNA.
For people living with HIV, exposure to hepatitis C virus (HCV) is linked to a higher risk of kidney disease and bone disorders.
The risk of heart attack for people with HIV may be nearly double that of the general population.
Researchers have used the cutting-edge CRISPR/Cas9 gene-editing technology to identify five potential targets for HIV treatments.
Fifteen years ago, Carl Siciliano founded the Ali Forney Center, now the largest U.S. housing program for homeless LGBT youth.